CRIS Current Research Information System

CICERO, ARRIGO FRANCESCO GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 24.813
NA - Nord America 24.088
AS - Asia 8.553
AF - Africa 897
SA - Sud America 178
OC - Oceania 111
Continente sconosciuto - Info sul continente non disponibili 13
Totale 58.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.998
IT - Italia 10.472
GB - Regno Unito 5.465
CN - Cina 3.124
DE - Germania 2.818
SG - Singapore 1.851
VN - Vietnam 1.665
IN - India 1.265
SE - Svezia 1.258
UA - Ucraina 1.126
FR - Francia 861
IE - Irlanda 730
RU - Federazione Russa 690
ZA - Sudafrica 463
EE - Estonia 378
CH - Svizzera 197
TG - Togo 160
CI - Costa d'Avorio 143
JO - Giordania 125
BG - Bulgaria 113
GR - Grecia 104
FI - Finlandia 97
AU - Australia 95
BE - Belgio 89
BR - Brasile 87
SC - Seychelles 86
HK - Hong Kong 85
NL - Olanda 80
PL - Polonia 75
CA - Canada 64
JP - Giappone 55
ES - Italia 52
TR - Turchia 51
KR - Corea 50
CL - Cile 42
IR - Iran 41
PE - Perù 39
AT - Austria 38
RO - Romania 36
PK - Pakistan 35
ID - Indonesia 30
LB - Libano 30
NG - Nigeria 24
MY - Malesia 20
TW - Taiwan 20
MX - Messico 17
NZ - Nuova Zelanda 16
HR - Croazia 15
RS - Serbia 15
CZ - Repubblica Ceca 14
PH - Filippine 14
AE - Emirati Arabi Uniti 13
AL - Albania 12
NO - Norvegia 12
LK - Sri Lanka 11
KZ - Kazakistan 10
PT - Portogallo 10
TH - Thailandia 10
LU - Lussemburgo 9
SA - Arabia Saudita 9
EU - Europa 8
MC - Monaco 8
BD - Bangladesh 7
EG - Egitto 7
IQ - Iraq 7
SI - Slovenia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DK - Danimarca 5
EC - Ecuador 5
HU - Ungheria 5
IL - Israele 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
UZ - Uzbekistan 5
AR - Argentina 4
LT - Lituania 4
CU - Cuba 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
LV - Lettonia 3
MT - Malta 3
SM - San Marino 3
CY - Cipro 2
GT - Guatemala 2
KE - Kenya 2
KH - Cambogia 2
MA - Marocco 2
MN - Mongolia 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
BZ - Belize 1
CO - Colombia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MD - Moldavia 1
MK - Macedonia 1
Totale 58.648
Salva come PNG Salva come JPEG
Città #
Southend 4.932
Fairfield 3.494
Ashburn 1.761
Woodbridge 1.727
Chandler 1.719
Wilmington 1.561
Singapore 1.553
Seattle 1.489
Princeton 1.405
Houston 1.381
Cambridge 1.195
Dong Ket 1.055
Ann Arbor 849
Milan 839
Dublin 712
Jacksonville 678
Rome 606
Bologna 567
Westminster 537
Padova 504
Nanjing 496
Berlin 383
Santa Clara 359
Turin 297
Saint Petersburg 257
Bremen 242
San Diego 239
Jinan 215
Naples 205
Shenyang 199
Florence 166
Beijing 163
Nanchang 161
Lomé 160
Mülheim 147
Abidjan 143
Hebei 139
Amman 124
Des Moines 120
Medford 118
Changsha 117
Tianjin 114
Sofia 109
Dearborn 102
Bari 100
Los Angeles 98
Boardman 96
San Venanzo 96
Olalla 91
Shanghai 91
Verona 89
Bern 88
Norwalk 87
Mahé 81
Jiaxing 80
Redwood City 79
Palermo 78
Brussels 75
Redmond 75
Catania 73
Zhengzhou 72
Guangzhou 71
Falls Church 69
Ningbo 66
Genoa 65
Haikou 60
Parma 60
Helsinki 59
Taizhou 56
Hangzhou 52
Bühl 45
Tokyo 45
Chicago 44
Kunming 44
Hong Kong 43
New York 43
London 41
Paris 41
Cagliari 39
Lima 39
Brescia 38
Lanzhou 37
Lappeenranta 36
Warsaw 35
Melbourne 34
Reggio Emilia 34
Mountain View 33
Perugia 33
Shenzhen 33
Taiyuan 33
Xi'an 33
Amsterdam 30
Monza 28
San Francisco 28
Wuhan 28
Pescara 25
Rimini 25
Forlì 24
Fuzhou 24
Torino 24
Totale 36.385
Salva come PNG Salva come JPEG
Nome #
La fame d’amore: un bambino che sta bene non piange. 6.292
Regressione completa di xantelasmi palpebrali in seguito a prolungatra terapia con statine: Case Report 1.142
Lo studio Brisighella: 40 anni di ricerca nella prevenzione delle malattie cardiovascolari. 799
Combined action of SAMe, Folate, and Vitamin B12 in the treatment of mood disorders: a review. 515
I lactotripeptidi IPP e VPP riducono la pressione arteriosa sistolicanei soggetti europei? Una metaanlisi degli studi randomizzati controllati. 354
Miglioramento dell'hepatic steatosi index in pazienti dislipidemici ed in sovrappeso trattati con nutraceutici ipolipemizzanti. 259
Capacità di efflusso del colesterolo e rigidità arteriosa nei soggetti sani: i dati del Brisighella Heart Study. 257
Pharmanutrition and Functional food 214
A meta-analysis of Italian and Estonian individuals shows an effect of common variants in HMGCR on blood apoB levels 189
Bioactive peptides in cereals and legumes: agronomical, biochemical and clinical aspects. 174
Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study 157
A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence 149
Cardiovascular risk factors and hearing impairment: a non-automatic correlation 148
Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4. 147
Effect of apple polyphenols on vascular oxidative stress and endothelium function: A translational study 147
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 145
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome. 143
Nutraceutici ed alimenti funzionali in medicina preventiva. 140
Adipokines and sexual hormones associated with the components of the metabolic syndrome in pharmacologically untreated subjects: data from the Brisighella Heart Study. 137
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial. 136
Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related with the lipid oxidative damage: the EUROLIVE Study. 136
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials. 136
Is the 2020 Sampson equation the best formula for LDL-C estimation? 135
Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial. 133
Short-Term Hemodynamic Effects of Modern Wheat Products Substitution in Diet with Ancient Wheat Products: A Cross-Over, Randomized Clinical Trial 133
1A.11: ASSOCIATION OF KIF6 AND HMGCR LOCI WITH CARDIOMETABOLIC PHENOTYPES AND RESPONSE TO STATIN THERAPY IN THE BRISIGHELLA COHORT 132
A comparison study of Lp(a) plasma levels distributions between normo- and hypertensive subjects with high BMI. 131
null 131
Wath are the major risk factors for type II diabetes development in the historical cohort of the Brisighella heart study? A 16-years follow-up 129
Treatment of massive hypertriglyceridemia resistant to PUFA and fibrates: a possible role for the coenzyme Q10? 128
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load. 128
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome. 127
Epidemiologia delle malattie cerebrovascolari. 126
Changes in peak systolic velocity induced by chronic therapy with phosphodiesterase type 5 inhibitor. 126
Arterial stiffness, sugar-sweetened beverages and fruits intake in a rural population sample: Data from the brisighella heart study 126
Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates. 125
Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects. 125
Adverse reactions related to drugs for headache treatment: clinical impact. 124
Effects of a new low dose soy protein β-sitosterol association on plasma lipid levels and oxidation 123
Effect of spontaneous changes in dietary components and lipoprotein(a) levels: Data from the Brisighella Heart Study 123
Metabolic Syndrome prevalence in Italy. 122
Canrenone on cardiovascular mortality in congestive heart failure: CanrenOne eFFects on cardiovascular mortality in patiEnts with congEstIve hearT failure: The COFFEE-IT study 122
Long-term effect of glimepiride and rosiglitazone on non-conventional cardiovascular risk factors in metformin-treated patients affected by metabolic syndrome: a randomized, double-blind clinical trial. 121
Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone. 120
Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial. 120
Relationship between lipid phenotypes, overweight, lipid lowering drug response and KIF6 and HMG-CoA genotypes in a subset of the brisighella heart study population 120
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study. 119
Nutraceutical approach to Non-alcoholic fatty liver disease (NAFLD): the available clinical evidence. 119
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. 118
null 118
Relative role of major risk factors for Type 2 Diabetes development in the historical cohort of the Brisighella Heart Study: an 8-years follow-up. 117
Effects of a standardized oral fat load on vascular remodelling markers in healthy subjects. 117
Sources of variabilità of plasma HDL-cholesterol levels. 116
Association between not HDL cholesterol levels and hypertension in the Brisighella Hart Study. 116
Rice bran and its main components: potential role in the management of cardiovascular disease risk. 116
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients. 116
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride. 116
Antidiabetic properties of berberine: from cellular pharmacology to clinical effects. 116
Novel role of the nutraceutical bioactive compound Berberine in lectin-like OxLDL receptor 1 -mediated endothelial dysfunction in comparison to Lovastatin 116
Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study. 115
Cocoa bioactive compounds: significance and potential for the maintenance of skin health. 115
Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: the available clinical data 115
High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects 115
Comparison of orlistat treatment and placebo in obese type 2 diabetic patients. 114
25-Hydroxy vitamin D levels and endothelial vasodilator function in normotensive women. 114
2B02: SERUM URIC ACID LEVEL, BUT NOT RENAL FUNCTION OR ARTERIAL STIFFNESS, IS ASSOCIATED TO WORSE BLOOD PRESSURE CONTROL IN GENERAL PRACTICE: DATA FROM THE BRISIGHELLA HEART STUDY 113
An evidence-based review on urate-lowering treatments: Implications for optimal treatment of chronic hyperuricemia 113
A Randomized Placebo-Controlled Clinical Trial to Evaluate the Medium-Term Effects of Oat Fibers on Human Health: The Beta-Glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) Study 113
Prevalence and the relative role of the main predictors of metabolic syndrome development in the hystorical cohort of the Brisighella heart study: 16-years follow-up 112
REVERSAL and PROVE-IT: are clinically oriented trials really better than "pure" scientific studies? 112
Effects of lactotripeptides assumed as functional food on office and 24-hour blood pressure, stress-induced blood pressure increase, pulse wave velocity and cardiac output related parameters: a rondomized, double-blindd, clinical trial. 112
Matrix Metalloproteinase-2, -9 and Tissue Inhibitor Metalloproteinase-1 in Patients with Hypertension Before and After Doxazosin Therapy. 112
Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study 112
Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. 111
Candesartan effect on inflammation in hypertension. 111
Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patients. 111
Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women. 111
Ruolo di lacidipina nel paziente iperteso 110
null 110
Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy. 110
The influence of statin medications on Prostate Specific Antigen levels. 109
Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: a 1-year, double-blind, randomized clinical trial. 109
Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study 109
A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study. 109
Morbidity and mortality in a population of patients affected by heart failure and chronic obstructive pulmonary disease: an observational study. 109
Amount of physical activity in middle-age hypertensive patients. 108
Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results. 108
Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study 108
The severity of coronary atherosclerosis in diabetic and non-diabetic metabolic syndrome patients diagnosed according to different criteria and undergoing elective angiography 107
Physical activity, exercise and cardiovascular health 107
Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review. 107
A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parametersand β-cell function 107
Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). 106
Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study. 106
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial. 105
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome. 105
Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients 104
Relazione tra livelli sierici di acido urico e rigidità arteriosa in un campione di adulti-anziani: i dati del Brisighella Heart Study 104
Changes in levels of serum cholesterol and development of hypertension in the Brisighella Heart Study. 104
L'attività fisica durante il tempo libero e la mortalità per malattie cardiovascolari: i dati del Brisighella Heart Study. 104
Totale 20.962
Salva come PNG Salva come JPEG
Categoria #
all - tutte 152.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.439
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.942 0 0 0 769 1.277 1.317 1.589 2.027 1.862 904 438 759
2020/20218.225 1.668 677 382 387 181 337 180 487 881 477 412 2.156
2021/20229.845 897 307 641 563 1.075 683 204 876 467 363 1.956 1.813
2022/202310.255 1.192 1.195 445 1.388 658 592 476 721 1.631 493 949 515
2023/20246.508 248 604 384 395 432 460 462 459 422 897 803 942
2024/20257.230 1.240 3.188 1.987 815 0 0 0 0 0 0 0 0
Totale 60.320